Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ziprasidone Augmentation in Major Depressive Disorder
NCT01168674Phase 4Completed
- Sponsor
- Tufts Medical Center
- Start
- Feb 2010
- Primary completion
- Dec 2011
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of ziprasidone in major depressive disorder (MDD), sponsored by Tufts Medical Center. Started Feb 2010; status: completed.
02
Drugs
ziprasidone
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01168674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01168674.